Suppr超能文献

转谷氨酰胺酶或磷脂酶A2抑制剂对乳腺外植体中催乳素受体下调及酪蛋白和DNA合成刺激的影响。

Effects of transglutaminase or phospholipase A2 inhibitors on down-regulation of prolactin receptors and stimulation of casein and DNA synthesis in mammary gland explants.

作者信息

Dusanter-Fourt I, Djiane J, Houdebine L M

出版信息

Mol Cell Endocrinol. 1983 Aug;31(2-3):287-99. doi: 10.1016/0303-7207(83)90155-7.

Abstract

A number of compounds have been found to inhibit the internalization of alpha 2-macroglobulin and/or epidermal growth factor into fibroblasts. Using the same inhibitor we tried to block the down-regulation of prolactin receptors, supposed to mirror internalization of PRL receptors, in order to investigate the possible role of internalization in the mechanism of prolactin action. In rabbit mammary cells it appeared that bacitracin and ethylamine completely block prolactin receptor down-regulation, but dansylcadaverine, the most potent inhibitor of transglutaminase, was without effect. The blockage of phospholipase A2 by chlorpromazine or bromophenacyl bromide (BPB) was without effect on the down-regulation of prolactin receptor. Subcellular distribution of [125I]oPRL has been studied after incubation with or without these various inhibitors after fractionation of mammary gland homogenate on sucrose gradient. Any of these compounds was able to increase the labelling of prolactin receptors located in plasma membrane fractions, suggesting that the rate of internalization of prolactin was not modified. In addition, none of these compounds inhibited the stimulation of beta-casein and DNA synthesis by prolactin. These results suggest that both transglutaminase and phospholipase A2 are not involved in the mechanism of prolactin-induced down-regulation of prolactin receptors, although bacitracin and ethylamine are able to block this phenomenon probably by different mechanism. In all cases, inductions of mitogenesis and beta-casein synthesis by prolactin in the rabbit mammary cells were not modified by the various compounds utilized. We conclude that neither transglutaminase nor phospholipase A2 are involved in the internalization of prolactin-receptor complexes, although bacitracin, ethylamine and quinacrine are able to block the down regulation of prolactin receptors by other means.

摘要

已发现多种化合物可抑制α2-巨球蛋白和/或表皮生长因子进入成纤维细胞。我们使用相同的抑制剂试图阻断催乳素受体的下调,推测这反映了PRL受体的内化过程,以研究内化在催乳素作用机制中的可能作用。在兔乳腺细胞中,杆菌肽和乙胺似乎完全阻断了催乳素受体的下调,但最有效的转谷氨酰胺酶抑制剂丹磺酰尸胺却没有效果。氯丙嗪或溴苯甲酰溴(BPB)对磷脂酶A2的阻断对催乳素受体的下调没有影响。在乳腺匀浆经蔗糖梯度分级分离后,分别在有无这些不同抑制剂的情况下孵育,研究了[125I]oPRL的亚细胞分布。这些化合物中的任何一种都能够增加位于质膜部分的催乳素受体的标记,表明催乳素的内化速率没有改变。此外,这些化合物均未抑制催乳素对β-酪蛋白和DNA合成的刺激。这些结果表明,转谷氨酰胺酶和磷脂酶A2均不参与催乳素诱导的催乳素受体下调机制,尽管杆菌肽和乙胺可能通过不同机制阻断这一现象。在所有情况下,所用的各种化合物均未改变催乳素在兔乳腺细胞中诱导的有丝分裂和β-酪蛋白合成。我们得出结论,转谷氨酰胺酶和磷脂酶A2均不参与催乳素-受体复合物的内化,尽管杆菌肽、乙胺和奎纳克林能够通过其他方式阻断催乳素受体的下调。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验